Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Henlius Biotech (2696 HK)
Watchlist
109
Analysis
Health Care
•
China
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Eoflow
•
26 May 2024 07:00
Last Week in Event SPACE: Mitsui Matsushima, L'Occitane, Prosus/Tencent, EOFlow
The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...
David Blennerhassett
Follow
446 Views
Share
bullish
•
Modec Inc
•
26 May 2024 01:17
Weekly Deals Digest (26 May) - Henlius, HKTV, SciClone, KFC, Best World, PropertyGuru, Modec
Last week, notable developments occurred in Event-Driven (Henlius, HKTV, SciClone, KFC, Best World, PropertyGuru) and ECM (Modec).
Arun George
Follow
444 Views
Share
bullish
•
BHP Group Ltd
•
25 May 2024 15:00
(Mostly) Asia-Pac M&A: KFC Holdings Japan, Shanghai Henlius, Alumina, BHP/ Anglo American, SciClone
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
455 Views
Share
bullish
•
Akeso Biopharma Inc
•
16 Apr 2024 23:56
[Blue Lotus Healthcare Sector Update]: Bottom-Fishing at the Bottom of the Business Cycle
Liquidity crises in healthcare innovation present buying opportunity;PD-1 exceeds expectations with 20%YoY growth forecast for 2024;Biosimilars...
Blue Lotus Research Institute
Follow
210 Views
Share
bullish
•
Akeso Biopharma Inc
•
20 Mar 2024 18:39
Akeso Inc Placement - A Small One to Digest, Momentum Has Been Strong
Akeso Biopharma Inc (9926 HK) is looking to raise US$155m from its primary placement. Representing 5.7 days of its three month ADV, the deal would...
Clarence Chu
Follow
394 Views
Share
First
Previous
6
7
8
9
10
11
12
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.2
x